Short interest screen · refreshed after the Nov 12, 2026 close
Highest days to cover: Healthcare
Short positions that would take the longest to unwind at normal trading volume. Days to cover divides the shares sold short by average daily volume. A higher number means short sellers would need more time to buy back shares, which can make a rally sharper.
| # | Company | Price | Today | Days to cover | Short % float | Δ short int. | Mkt cap |
|---|---|---|---|---|---|---|---|
| 1 | GALTGalectin TherapeuticsHealthcare | $3.14 | −4.56% | 46.3 | 13.4% | −2% | $316.7M |
| 2 | TLSITriSalus Life SciencesHealthcare | $2.52 | +9.57% | 28.5 | 8.5% | −4% | $155.5M |
| 3 | DMACDiaMedica TherapeuticsHealthcare | $9.33 | −3.42% | 24.8 | 20.6% | −4% | $503.1M |
| 4 | ZBIOZenas BioPharmaHealthcare | $27.64 | −3.69% | 24.1 | 36.4% | −9% | $1.87B |
| 5 | CAMPCAMP4 TherapeuticsHealthcare | $4.09 | −2.62% | 23.7 | 7.7% | −6% | $256.7M |
| 6 | RYTMRhythm PharmaceuticalsHealthcare | $109.86 | −2.05% | 23.3 | 18.1% | +6% | $7.62B |
| 7 | ABEOAbeona TherapeuticsHealthcare | $2.29 | −0.43% | 21.7 | 35.5% | −2% | $141.2M |
| 8 | RLAYRelay TherapeuticsHealthcare | $18.08 | −8.32% | 20.7 | 27.7% | −1% | $3.99B |
| 9 | BRVEBraveheart BioHealthcare | $20.50 | −1.91% | 19.6 | 11.4% | +5% | $1.85B |
| 10 | IMRXImmuneeringHealthcare | $3.67 | −3.17% | 19.2 | 26.1% | −11% | $237.7M |
| 11 | TGTXTG TherapeuticsHealthcare | $64.56 | −1.82% | 18.9 | 19.5% | −3% | $9.76B |
| 12 | CRVSCorvus PharmaceuticalsHealthcare | $10.62 | −7.41% | 18.9 | 24.1% | −1% | $895.8M |
| 13 | RDNTRadNetHealthcare | $76.04 | −2.61% | 18.0 | 12.7% | −2% | $5.99B |
| 14 | LBRXLB PharmaceuticalsHealthcare | $42.46 | −5.03% | 18.0 | 25.6% | +11% | $1.37B |
| 15 | EDITEditas MedicineHealthcare | $2.14 | −10.08% | 17.6 | 26.0% | +1% | $330.3M |
| 16 | SPTXSeaport TherapeuticsHealthcare | $20.13 | −5.54% | 17.4 | 19.3% | 0% | $1.08B |
| 17 | ASMBAssembly BiosciencesHealthcare | $20.18 | −9.79% | 17.0 | 29.2% | +4% | $410.9M |
| 18 | NGNENeurogeneHealthcare | $23.90 | −4.78% | 17.0 | 44.2% | +12% | $494.8M |
| 19 | PTGXProtagonist TherapeuticsHealthcare | $134.38 | −0.36% | 16.9 | 16.7% | −1% | $8.77B |
| 20 | TCMDTactile Systems TechnologyHealthcare | $26.82 | −1.14% | 16.7 | 12.6% | −1% | $600.8M |
| 21 | RNACCartesian TherapeuticsHealthcare | $6.36 | −7.63% | 16.5 | 14.0% | +2% | $193.8M |
| 22 | CBIOCrescent BiopharmaHealthcare | $14.37 | −2.61% | 16.3 | 14.8% | −6% | $533.8M |
| 23 | DSGNDesign TherapeuticsHealthcare | $10.58 | −1.76% | 16.2 | 20.7% | −5% | $677.5M |
| 24 | RNAAtrium TherapeuticsHealthcare | $7.50 | −5.78% | 16.1 | 23.1% | +1% | $128.3M |
| 25 | AKTSAktis OncologyHealthcare | $16.28 | −4.46% | 16.0 | 18.7% | +3% | $905.5M |
| 26 | SANASana BiotechnologyHealthcare | $2.01 | −12.23% | 15.8 | 22.0% | −1% | $602.3M |
| 27 | PRTAProthenaHealthcare | $8.23 | −5.73% | 15.7 | 19.3% | 0% | $422.6M |
| 28 | GLUEMonte Rosa TherapeuticsHealthcare | $9.31 | −9.70% | 15.7 | 28.4% | +1% | $795.5M |
| 29 | ENTXEntera BioHealthcare | $3.22 | 0.00% | 15.6 | 4.4% | +27% | $560.7M |
| 30 | ODTXOdyssey TherapeuticsHealthcare | $20.10 | −4.24% | 15.4 | 13.9% | +2% | $966.2M |
| 31 | TYRATyra BiosciencesHealthcare | $19.77 | −5.75% | 15.3 | 27.6% | +4% | $1.37B |
| 32 | IMVTImmunovantHealthcare | $35.05 | −5.37% | 15.3 | 21.4% | +2% | $7.25B |
| 33 | NVCTNuvectis PharmaHealthcare | $20.23 | −3.67% | 15.2 | 12.4% | +6% | $695.7M |
| 34 | CCCCC4 TherapeuticsHealthcare | $2.77 | −4.15% | 15.1 | 47.3% | +9% | $363.7M |
| 35 | DERMJourney MedicalHealthcare | $4.39 | −1.13% | 15.1 | 25.6% | +3% | $123.9M |
| 36 | CARLCarlsmedHealthcare | $17.30 | −6.99% | 15.1 | 12.8% | +13% | $474.1M |
| 37 | RZLTRezolute, Inc. Common Stock (NV)Healthcare | $3.87 | −4.91% | 14.9 | 21.8% | −3% | $374.3M |
| 38 | TSHATaysha Gene TherapiesHealthcare | $4.21 | −1.64% | 14.8 | 18.2% | +4% | $1.37B |
| 39 | KEQUKewaunee ScientificHealthcare | $35.94 | +7.59% | 14.4 | 1.8% | −3% | $104.1M |
| 40 | CVCapsoVisionHealthcare | $6.27 | 0.00% | 14.3 | 5.7% | −11% | $333.6M |
| 41 | GYREGyre TherapeuticsHealthcare | $4.30 | +0.94% | 14.2 | 13.4% | +16% | $470.6M |
| 42 | CYTKCytokineticsHealthcare | $56.16 | −4.05% | 14.2 | 14.8% | −4% | $7.82B |
| 43 | HROWHarrowHealthcare | $28.30 | −3.64% | 14.1 | 23.0% | −5% | $1.06B |
| 44 | JBIOJade BiosciencesHealthcare | $15.87 | −4.05% | 14.1 | 19.2% | −7% | $1.01B |
| 45 | BEAMBeam TherapeuticsHealthcare | $24.03 | −6.90% | 13.7 | 31.8% | −1% | $2.49B |
| 46 | AURAAura BiosciencesHealthcare | $7.11 | −6.57% | 13.7 | 11.3% | −4% | $740.0M |
| 47 | TECXTectonic TherapeuticHealthcare | $21.04 | −4.19% | 13.7 | 20.4% | +7% | $411.3M |
| 48 | SRRKScholar Rock HoldingHealthcare | $43.16 | −7.38% | 13.6 | 21.5% | +6% | $5.27B |
| 49 | CGEMCullinan TherapeuticsHealthcare | $10.19 | −10.22% | 13.3 | 14.8% | +4% | $661.5M |
| 50 | CADLCandel TherapeuticsHealthcare | $8.39 | −9.00% | 13.3 | 22.1% | +2% | $642.0M |
Data guard: 1 stock withheld — KPLT (float record is implausibly small). They return once the float record is verified.
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.